{
 "drug": "Sufentanil Citrate Injection",
 "asOf": "2026-08-25",
 "status": "in-shortage",
 "since": "05/03/2022",
 "dayN": 1575,
 "cat": "Analgesia/Addiction",
 "companies": [
  "Hikma Pharmaceuticals USA, Inc.",
  "Hospira, Inc., a Pfizer Company"
 ],
 "reasons": [
  "Other"
 ],
 "records": [
  {
   "update_type": "Reverified",
   "initial_posting_date": "05/03/2022",
   "package_ndc": "17478-050-01",
   "generic_name": "Sufentanil Citrate Injection",
   "contact_info": "800-631-2174",
   "availability": "Unavailable",
   "related_info": "Not currently manufactured",
   "update_date": "08/13/2026",
   "therapeutic_category": [
    "Analgesia/Addiction",
    "Pediatric"
   ],
   "dosage_form": "Injection",
   "presentation": "Sufentanil Citrate, Injection, 50 mcg/1 mL (NDC 17478-050-01)",
   "company_name": "Hikma Pharmaceuticals USA, Inc.",
   "shortage_reason": "Other",
   "status": "Current"
  },
  {
   "update_type": "Reverified",
   "initial_posting_date": "05/03/2022",
   "package_ndc": "17478-050-05",
   "generic_name": "Sufentanil Citrate Injection",
   "contact_info": "800-631-2174",
   "availability": "Unavailable",
   "related_info": "Not currently manufactured",
   "update_date": "08/13/2026",
   "therapeutic_category": [
    "Analgesia/Addiction",
    "Pediatric"
   ],
   "dosage_form": "Injection",
   "presentation": "Sufentanil Citrate, Injection, 50 mcg/1 mL (NDC 17478-050-05)",
   "company_name": "Hikma Pharmaceuticals USA, Inc.",
   "shortage_reason": "Other",
   "status": "Current"
  },
  {
   "update_type": "Revised",
   "initial_posting_date": "05/03/2022",
   "package_ndc": "0409-3382-21",
   "generic_name": "Sufentanil Citrate Injection",
   "contact_info": "844-646-4398",
   "availability": "Unavailable",
   "related_info": "Next Delivery: August 2026; Estimated Recovery: September 2026; Shortage per Manufacturer: Manufacturing Delay",
   "openfda": {
    "application_number": [
     "ANDA074534"
    ],
    "brand_name": [
     "SUFENTANIL CITRATE"
    ],
    "generic_name": [
     "SUFENTANIL CITRATE"
    ],
    "manufacturer_name": [
     "Hospira, Inc."
    ],
    "product_ndc": [
     "0409-3382"
    ],
    "product_type": [
     "HUMAN PRESCRIPTION DRUG"
    ],
    "route": [
     "EPIDURAL",
     "INTRAVENOUS"
    ],
    "substance_name": [
     "SUFENTANIL CITRATE"
    ],
    "rxcui": [
     "1809097"
    ],
    "spl_id": [
     "2f400934-519c-4d94-a8d5-bad870eaa1a6"
    ],
    "spl_set_id": [
     "20293943-46ff-4345-1aa4-929b4e017a25"
    ],
    "package_ndc": [
     "0409-3382-11",
     "0409-3382-21"
    ],
    "unii": [
     "S9ZFX8403R"
    ]
   },
   "update_date": "08/07/2026",
   "therapeutic_category": [
    "Analgesia/Addiction",
    "Pediatric"
   ],
   "dosage_form": "Injection",
   "presentation": "Sufentanil Citrate, Injection, 50 ug/1 mL (NDC 0409-3382-21)",
   "company_name": "Hospira, Inc., a Pfizer Company",
   "shortage_reason": "Other",
   "status": "Current"
  },
  {
   "update_type": "Reverified",
   "initial_posting_date": "05/03/2022",
   "package_ndc": "17478-050-02",
   "generic_name": "Sufentanil Citrate Injection",
   "contact_info": "800-631-2174",
   "availability": "Unavailable",
   "related_info": "Not currently manufactured",
   "update_date": "08/13/2026",
   "therapeutic_category": [
    "Analgesia/Addiction",
    "Pediatric"
   ],
   "dosage_form": "Injection",
   "presentation": "Sufentanil Citrate, Injection, 50 mcg/1 mL (NDC 17478-050-02)",
   "company_name": "Hikma Pharmaceuticals USA, Inc.",
   "shortage_reason": "Other",
   "status": "Current"
  }
 ]
}